Abstract
We present a case of a 23 year-old male treated for Hodgkin’s lymphoma who developed diffuse large B-cell lymphoma (DLBCL) 8 years after achieving remission. 18F-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG PET-CT) was done, which revealed extensive extranodal involvement of bilateral atria, bilateral kidneys, ileo-caecal junction and left testis along with mesenteric and retroperitoneal lymph nodal involvement. Renal and cardiac lesions were not detected by contrast-enhanced CT. Simultaneous lymphomatous involvement of rare sites such as heart, kidneys and testis in a single patient has not been reported before.
This is a preview of subscription content, log in via an institution to check access.
References
Armitage JO, Longo DL. Malignancies of lymphoid cells. In: Kasper DL, Braunwald E, Fauci AS, et al., editors. (15): Harrison’s principles of Internal Medicine. New York: The McGraw-Hill Companies; 2005. p. 641–55.
Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease. RadioGraphics. 2010;30:269–91.
Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin’s Disease. Radiol Clin N Am. 2007;45:697–709.
Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med. 2008;113:578–90.
Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin’s and non-Hodgkin’s lymphomas. Radiol Clin North Am. 2004;42:1083–100.
Jerusalem G, Bequin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;15:429–33.
Specht L. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol. 2007;17:190–7.
Yin Y, Qing F, Li X, Du B, Li N, Li Y. Non Hodgkin’s lymphoma of the testicle and bilateral adrenals detected by 18F-FDG PET/CT. Exp Theor Med. 2011;2:817–20.
Julian A, Wagner T, Ysebaert L, Chabbert V, Payoux P. FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin’slymphoma. Eur J Nucl Med Mol Imaging. 2011;38:1174.
Kaderli AA, Baran I, Aydin O, Bicer M, Akpinar T, Ozkalemkas F, et al. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma. Eur J Echocardiogr. 2010;11:74–6.
Su HY, Huang HL, Sun CM, Hou SM, Chen ML. Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT. Clin Nucl Med. 2009;34:298–301.
d’Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer. 1991;27:1201–8.
Economopoulos T, Asprou N, Stathakis N, Papageorgiou E, Dervenoulas J, Xanthaki K, et al. Primary extranodal non-Hodgkin’s lymphoma in adults: clinicopathological and survival characteristics. Leuk Lymphoma. 1996;21:131–6.
Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol. 2005;23:2797–804.
Economopoulos T, Papageorgiou S, Rontogianni D, Kaloutsi V, Fountzilas G, Tsatalas C, et al. Multifocal Extranodal Non-Hodgkin Lymphoma: α clinicopathologic study of 37 Cases in Greece, a Hellenic Cooperative Oncology Group Study. Oncologist. 2005;10:734–8.
Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9.
Levine MS, Rubesin SE, Pantongrag-Brown L, Buck JL, Herlinger H, et al. Non-Hodgkin’s lymphoma of the gastrointestinal tract: radiographic findings. AJR Am J Roentgenol. 1997;168:165–72.
Heiken JP, Gold RP, Schnur MJ, King DL, Bashist B, Glazer HS. Computed tomography of renal lymphoma with ultrasound correlation. J Comput Assist Tomogr. 1983;7:245–50.
Sheth S, Ali S, Fishman E. Imaging of renal lymphoma: patterns of disease with patholgioc correlation. RadioGraphics. 2006;26:1151–68.
Villa D, Connors JM, Sehn LH, Gascoyne RD, Savage KJ. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse. Haematologica. 2011;96:1002.
Guermazi A, Brice P, de Kerviler EE, Fermé C, Hennequin C, Meignin V, et al. Extranodal Hodgkin disease: spectrum of disease. RadioGraphics. 2011;21:161–79.
van den Bos EJ, Baks T, Bakker J, van Gelder W, Levin MD. Severe right ventricular inflow obstruction by non-Hodgkin lymphoma. Br J Haematol. 2008;142:858.
Leite NP, Kased N, Hanna RF, Brown MA, Pereira JM, Cunha R, et al. Cross-sectional Imaging of Extranodal Involvement in Abdominopelvic Lymphoproliferative Malignancies. RadioGraphics. 2007;27:1613–34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhull, V.S., Sharma, P., Singla, S. et al. Extensive Extranodal Involvement of Rare Sites in Non Hodgkin’s Lymphoma Detected on 18F- FDG PET-CT: A Case Report. Nucl Med Mol Imaging 47, 125–129 (2013). https://doi.org/10.1007/s13139-012-0183-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-012-0183-3